Triamterene

This section needs additional citations for verification. Please help improve this article by adding citations to reliable sources in this section. Unsourced material may be challenged and removed. (June 2012) (Learn how and when to remove this message)

Triamterene

Clinical data
Trade names	Dyrenium, others
AHFS/Drugs.com	Monograph
MedlinePlus	a682337
Pregnancy category	AU: C
Routes of administration	By mouth
ATC code	C03DB02 (WHO)
Legal status
Legal status	AU: S4 (Prescription only) UK: POM (Prescription only) US: WARNING[1]Rx-only
Pharmacokinetic data
Bioavailability	30-70%
Protein binding	67%
Metabolism	hydroxylation to para-hydroxytriamterene
Elimination half-life	1-2 hours, active metabolite 3 hours
Excretion	renal <50%, 21% unchanged
Identifiers
IUPAC name 6-phenylpteridine-2,4,7-triamine
CAS Number	396-01-0 Y
PubChem CID	5546
IUPHAR/BPS	4329
DrugBank	DB00384 Y
ChemSpider	5345 Y
UNII	WS821Z52LQ
KEGG	D00386 N
ChEMBL	ChEMBL585 Y
CompTox Dashboard (EPA)	DTXSID6021373
ECHA InfoCard	100.006.278
Chemical and physical data
Formula	C12H11N7
Molar mass	253.269 g·mol−1
InChI InChI=1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19) Y Key:FNYLWPVRPXGIIP-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Triamterene (traded under names such as Dyrenium and Dytac) is a potassium-sparing diuretic often used in combination with thiazide diuretics for the treatment of high blood pressure or swelling. The combination with hydrochlorothiazide, is known as hydrochlorothiazide/triamterene.